Patents by Inventor Michael MILDNER

Michael MILDNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC REACTION
    Publication number: 20230000910
    Abstract: The present invention relates to a composition comprising a supernatant of a peripheral blood mononuclear cell (PBMC) cell culture for use in the treatment or prevention of an allergy or an allergic reaction caused by the administration of at least one food and/or inhalation allergen or by the systemic administration of at least one drug to a human or mammal body.
    Type: Application
    Filed: December 23, 2020
    Publication date: January 5, 2023
    Inventors: Hendrik Jan Ankersmit, Michael Mildner
  • Potency assay of secretomes
    Patent number: 11333662
    Abstract: The present invention relates to a method for determining the potency of a supernatant of a mammalian cell culture to be used in the treatment of an inflammatory condition.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: May 17, 2022
    Assignee: APOSCIENCE AG
    Inventors: Hendrik Jan Ankersmit, Michael Mildner
  • POTENCY ASSAY OF SECRETOMES
    Publication number: 20200386740
    Abstract: The present invention relates to a method for determining the potency of a supernatant of a mammalian cell culture to be used in the treatment of an inflammatory condition.
    Type: Application
    Filed: December 19, 2018
    Publication date: December 10, 2020
    Inventors: Hendrik Jan ANKERSMIT, Michael MILDNER